Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | market report | table of contents
Germany Pharmaceuticals and Healthcare Report Q3 2008 (Business Monitor International)
- Market: Healthcare and Medical
- Report Title: Germany Pharmaceuticals and Healthcare Report Q3 2008
- View Report Summary: View Report Summary
- Report Type: Market Report
- Country: Germany
- Number of Pages: 71
Executive Summary 5
Germany Pharmaceuticals And Healthcare Industry SWOT . 6
Germany Political SWOT 7
Germany Economic SWOT 7
Pharmaceutical Business Environment Ratings .....8
Table: Western Europe Pharmaceutical Business Environment Ratings 8
Limits Of Potential Returns 8
Risks To Realisation Of Returns . 9
Germany – Market Summary ....10
Regulatory Regime 11
Intellectual Property Developments . 12
Pricing And Reimbursement Issues .. 14
Industry Developments ......17
Healthcare Sector . 17
Krankenkassen ...... 19
Foreign Industry ... 20
Wholesale Sector .. 23
Retail Sector 24
Biotechnology Sector ..... 27
Epidemiology . 29
Industry Forecast Scenario ....31
Overall Market Forecast 31
Table: German Drug Market Expenditure Forecasts .. 32
Key Growth Factors – Industry . 33
Table: German Health Expenditure Indicators, 2004-2012. 34
Key Growth Factors – Macroeconomic .... 35
Table: Germany – Macroeconomic Forecasts .. 37
Patented Market Forecast 38
Table: Germany’s Patented Market Indicators, 2004-2012. 39
Generics Market Forecasts ..... 40
Table: Germany’s Generic Drug Market Indicators, 2004-2012 41
OTC Market Forecast .... 42
Table: Germany’s OTC Market Indicators, 2004-2012 (US$mn unless otherwise stated) .. 43
Export/Import Forecasts 44
Table: Germany’s Pharmaceuticals Exports And Imports, 2004-2012 (US$mn) 45
Medical Devices Forecast 46
Table: Leading German Medical Device Players 47
Table: Germany’s Medical Device Market Indicators, 2006-2012 (US$bn unless otherwise stated) ... 48
Key Risks To BMI’s Forecast Scenario ..... 49
Competitive Landscape .....50
Company Profiles 51
GlaxoSmithKline (GSK) . 51
Pfizer .. 53
Novartis . 55
Sanofi-Aventis 56
Merck & Co . 58
Bayer .. 60
Boehringer Ingelheim .... 63
BMI Forecast Modelling .....67
How We Generate Our Pharmaceutical Industry Forecasts ..... 67
Pharmaceutical Industry 68
Pharmaceutical Business Environment Ratings Methodology .. 68
Ratings Overview .. 68
Table: Pharmaceutical Business Environment Indicators ... 69
Weighting... 69
Table: Weighting Of Components .... 70
Sources .... 70
Germany Pharmaceuticals And Healthcare Industry SWOT . 6
Germany Political SWOT 7
Germany Economic SWOT 7
Pharmaceutical Business Environment Ratings .....8
Table: Western Europe Pharmaceutical Business Environment Ratings 8
Limits Of Potential Returns 8
Risks To Realisation Of Returns . 9
Germany – Market Summary ....10
Regulatory Regime 11
Intellectual Property Developments . 12
Pricing And Reimbursement Issues .. 14
Industry Developments ......17
Healthcare Sector . 17
Krankenkassen ...... 19
Foreign Industry ... 20
Wholesale Sector .. 23
Retail Sector 24
Biotechnology Sector ..... 27
Epidemiology . 29
Industry Forecast Scenario ....31
Overall Market Forecast 31
Table: German Drug Market Expenditure Forecasts .. 32
Key Growth Factors – Industry . 33
Table: German Health Expenditure Indicators, 2004-2012. 34
Key Growth Factors – Macroeconomic .... 35
Table: Germany – Macroeconomic Forecasts .. 37
Patented Market Forecast 38
Table: Germany’s Patented Market Indicators, 2004-2012. 39
Generics Market Forecasts ..... 40
Table: Germany’s Generic Drug Market Indicators, 2004-2012 41
OTC Market Forecast .... 42
Table: Germany’s OTC Market Indicators, 2004-2012 (US$mn unless otherwise stated) .. 43
Export/Import Forecasts 44
Table: Germany’s Pharmaceuticals Exports And Imports, 2004-2012 (US$mn) 45
Medical Devices Forecast 46
Table: Leading German Medical Device Players 47
Table: Germany’s Medical Device Market Indicators, 2006-2012 (US$bn unless otherwise stated) ... 48
Key Risks To BMI’s Forecast Scenario ..... 49
Competitive Landscape .....50
Company Profiles 51
GlaxoSmithKline (GSK) . 51
Pfizer .. 53
Novartis . 55
Sanofi-Aventis 56
Merck & Co . 58
Bayer .. 60
Boehringer Ingelheim .... 63
BMI Forecast Modelling .....67
How We Generate Our Pharmaceutical Industry Forecasts ..... 67
Pharmaceutical Industry 68
Pharmaceutical Business Environment Ratings Methodology .. 68
Ratings Overview .. 68
Table: Pharmaceutical Business Environment Indicators ... 69
Weighting... 69
Table: Weighting Of Components .... 70
Sources .... 70
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
